I think at this point CytoDyn needs a large institutional investor who is willing to push management and stock price. We used to have no insider ownership until we the shareholders gave the management team shares a few weeks ago. So management doesn’t have a shirt in the game. Wall Street doesn’t have a shirt in the the game.

Is anyone aware of any big institutions who are invested in CytoDyn? No financial institutions support and not enough insider ownership has always been a red flag for me. I ignored the red flag here due to the science behind Leronlimab.

We need help from the big guys, otherwise the big guys will keep shorting this to keep their investments safe.